Historique de carrière de Steven J. Swanson
Anciens postes connus de Steven J. Swanson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 18/02/2015 | 15/10/2018 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Formation de Steven J. Swanson
| North Central College | Undergraduate Degree |
| University of Iowa | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
- Bourse
- Insiders
- Steven J. Swanson
- Expérience
